首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
METHOD FOR SYSTEMIC TREATMENT OF CATABOLIC CONDITIONS AND SYSTEMIC TISSUE INJURY.
摘要
申请公布号
EP0661990(A1)
申请公布日期
1995.07.12
申请号
EP19930920354
申请日期
1993.08.26
申请人
CELTRIX PHARMACEUTICALS, INC.
发明人
SOMMER, ANDREAS;MAACK, CHRISTOPHER, A.
分类号
C12P21/02;A61K38/27;A61K38/30;A61P1/04;A61P3/00;A61P43/00;C07K14/65;(IPC1-7):A61K38/00;A61K38/28;C07K7/00
主分类号
C12P21/02
代理机构
代理人
主权项
地址
您可能感兴趣的专利
NOVEL USE OF 1-(4-(5-CYANOINDOL-3YL)BUTYL)-4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE AND ITS PHYSIOLOGICAL ACCEPTABLE SALTS FOR THE TREATMENT OF BIPOLAR DISORDERS AND MANIA
SPORT APPARATUS
WOOD IMPREGNATION
PHTHALAZINONE PDE III/IV INHIBITORS
SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS HPPAR ALPHA ACTIVATORS
Process for preparing 1-(9'H-carbazol-4'-yloxy)-3-( 2''-(2'''- methoxy -phenoxy)-ethyl -amino)-propan-2-ol(carvedilol)
USE OF NMDA ANTAGONISTS FOR TREATMENT OF IRRITABLE BOWEL SYNDROME
NITRATE SALT OF ANTI-ULCER MEDICINE
PROCESS TO PRODUCE 4-HYDROXY-2-OXO-PYRANE DERIVATIVES USEFUL AS PROTEASE INHIBITORS
4-BROMO OR 4-IODO PHENYLAMINO BENZHYDROXAMIC ACID DERIVATIVES AND THEIR USE AS MEK INHIBITORS
(-)-4-AMINO-5-FLUORO-1-(2-HYDROXYMETHYL-1,3-OXATHIOLAN-5-YL)-(1H)-PYRIMIDIN-2-ONE
Bestruken pappersprodukt samt förfarande och anordning för framställning därav
PROCESSO E DISPOSITIVO PARA CONSOLIDAR A MANUTENCAO NUMA CALHA DE UM ACESSORIO QUALQUER A COLOCAR POR ENCAIXE NA BASE DA MESMA
DISPOSITIVO DESTINADO A ADUZIR VAPOR AO AR DE ADMISSAO DE UM MOTOR DE COMBUSTAO INTERNA
PACKAGE SUBSTRATE WITH ENHANCED FREEDOM DEGREE OF PRODUCT DESIGN BY SHORTENING LENGTH OF PLATING LEAD LINE AND MANUFACTURING METHOD THEREOF
METHOD FOR SPECIFYING PIXEL POSITIONS BY USING BEAM POSITION DETECTING DEVICE, METHOD FOR CORRECTING IMAGE OFFSET, AND IMAGE FORMING DEVICE
CLOSING SEQUENCE CONTROL DEVICE
METODO DE SELECCAO DE UM SAL PARA A PREPARACAO DE UM COMPLEXO DE INCLUSAO
PROTEINAS DE FUSAO DE CLASSE II DO CPH SOLUVEIS MONOVALENTES E MULTIVALENTES, E SUAS UTILIZACOES
CONTENEDOR CON PRODUCTO
